Read the full stored bill text
S T A T E O F N E W Y O R K
________________________________________________________________________
4640
2025-2026 Regular Sessions
I N S E N A T E
February 10, 2025
___________
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
printed to be committed to the Committee on Alcoholism and Substance
Use Disorders
AN ACT to amend the public health law, in relation to onsite overdose
response services and requiring certain locations and venues to main-
tain a supply of opioid antagonists
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
1 Section 1. Subdivisions 1, 3, 4 and 8 of section 3309 of the public
2 health law, subdivisions 1 and 3 as amended by chapter 42 of the laws of
3 2014, subparagraph (iv) of paragraph (a) of subdivision 3 and subdivi-
4 sion 4 as amended and subparagraph (v) of paragraph (a) of subdivision 3
5 as added by chapter 148 of the laws of 2020, subparagraph (vi) of para-
6 graph (a) of subdivision 3 and subdivision 8 as added by chapter 83 of
7 the laws of 2023, and subparagraph (v) of paragraph (b) of subdivision 3
8 as added by chapter 65 of the laws of 2016, are amended to read as
9 follows:
10 1. The commissioner is authorized to establish standards for approval
11 of any opioid overdose prevention program, ONSITE OVERDOSE RESPONSE
12 SERVICES, and opioid antagonist prescribing, dispensing, distribution,
13 possession and administration pursuant to this section which may
14 include, but not be limited to, standards for program directors, appro-
15 priate clinical oversight, training, record keeping and reporting.
16 3. (a) As used in this section:
17 (i) "Opioid antagonist" means a drug approved by the Food and Drug
18 Administration that, when administered, negates or neutralizes in whole
19 or in part the pharmacological effects of an opioid in the body. "Opioid
20 antagonist" shall be limited to naloxone and other medications approved
21 by the department for such purpose.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08571-01-5
S. 4640 2
1 (ii) "Health care professional" means a person licensed, registered or
2 authorized pursuant to title eight of the education law to prescribe
3 prescription drugs.
4 (iii) "Pharmacist" means a person licensed or authorized to practice
5 pharmacy pursuant to article one hundred thirty-seven of the education
6 law.
7 (iv) "Opioid antagonist recipient" [or "recipient"] means a person at
8 risk of experiencing an opioid-related overdose, or a family member,
9 friend or other person in a position to assist a person experiencing or
10 at risk of experiencing an opioid-related overdose, or an organization
11 registered as an opioid overdose prevention program pursuant to this
12 section or any person or entity or any person employed by the person or
13 entity.
14 (v) As used in this section, "entity" includes, but is not limited to,
15 A HEALTH CARE INSTITUTION, A NOT-FOR-PROFIT CHARITABLE ORGANIZATION, a
16 school district, public library, board of cooperative educational
17 services, county vocational education and extension board, charter
18 school, non-public elementary or secondary school, restaurant, bar,
19 retail store, shopping mall, barber shop, beauty parlor, theater, sport-
20 ing or event center, inn, hotel [or], motel OR PUBLIC INSTITUTIONS OR
21 BUILDINGS.
22 (vi) "Nightlife establishment" means an establishment that is open to
23 the public for entertainment or leisure, serves alcohol or where alcohol
24 is consumed on the premises, and conducts a large volume of business at
25 night. Such term includes, but is not limited to, bars, entertainment
26 venues, clubs and restaurants.
27 (VII) "ONSITE OVERDOSE RESPONSE SERVICES" MEANS THE PROVISION OF
28 TRAINED STAFF WHO MONITOR FOR SIGNS OF OVERDOSE AND RESPOND TO SUSPECTED
29 DRUG OVERDOSES TO PREVENT DEATH AND OTHER NEGATIVE HEALTH CONSEQUENCES
30 ASSOCIATED WITH DRUG USE, INCLUDING BY ADMINISTERING OPIOID ANTAGONISTS
31 WHEN APPROPRIATE.
32 (b)(i) A health care professional may prescribe by a patient-specific
33 or non-patient-specific prescription, dispense or distribute, directly
34 or indirectly, an opioid antagonist to an opioid antagonist recipient.
35 (ii) A pharmacist may dispense an opioid antagonist, through a
36 patient-specific or non-patient-specific prescription pursuant to this
37 paragraph, to an opioid antagonist recipient.
38 (iii) An opioid antagonist recipient may possess an opioid antagonist
39 obtained pursuant to this paragraph, may distribute such opioid antag-
40 onist to [a] ANOTHER OPIOID ANTAGONIST recipient, and may administer
41 such opioid antagonist to a person the OPIOID ANTAGONIST recipient
42 reasonably believes is experiencing an opioid overdose.
43 (iv) The provisions of this paragraph shall not be deemed to require a
44 prescription for any opioid antagonist that does not otherwise require a
45 prescription; nor shall it be deemed to limit the authority of a health
46 care professional to prescribe, dispense or distribute, or of a pharma-
47 cist to dispense, an opioid antagonist under any other provision of law.
48 (v) Any pharmacy with twenty or more locations in the state, shall
49 either: (1) pursue or maintain a non-patient-specific prescription with
50 an authorized health care professional to dispense an opioid antagonist
51 to a consumer upon request, as authorized by this section; or (2) regis-
52 ter with the department as an opioid overdose prevention program.
53 4. (a) Use of an opioid antagonist pursuant to this section shall be
54 considered first aid or emergency treatment for the purpose of any stat-
55 ute relating to liability.
S. 4640 3
1 (b) [A] AN OPIOID ANTAGONIST recipient, RECIPIENT OF ONSITE OVERDOSE
2 RESPONSE SERVICES, ENTITY PROVIDING ONSITE OVERDOSE RESPONSE SERVICES,
3 opioid overdose prevention program, person or entity, or any person
4 employed by the person or entity, acting reasonably and in good faith in
5 compliance with this section, shall not be subject to criminal, civil or
6 administrative liability solely by reason of such action.
7 8. The commissioner shall establish guidelines for onsite [opioid]
8 overdose response [capacity] SERVICES, INCLUDING in nightlife establish-
9 ments, SPORTING OR EVENT CENTERS, THEATERS, CONCERT VENUES, AND AMUSE-
10 MENT PARKS. SUCH GUIDELINES SHALL INCLUDE, BUT NOT BE LIMITED TO:
11 (A) MAINTAINING A SUPPLY OF UNEXPIRED OPIOID ANTAGONIST NASAL SPRAY;
12 AND
13 (B) HAVING EMPLOYED AND AT SUCH LOCATION WHENEVER IN OPERATION AT
14 LEAST TWO PERSONS TRAINED IN IDENTIFYING OPIOID OVERDOSES AND USING
15 OPIOID ANTAGONISTS.
16 § 2. Subdivision 2 of section 3309-b of the public health law, as
17 amended by chapter 16 of the laws of 2024, is amended to read as
18 follows:
19 2. A health care professional, OPIOID OVERDOSE PREVENTION PROGRAM,
20 PROVIDER OF ONSITE OVERDOSE RESPONSE SERVICES, or pharmacist is author-
21 ized to dispense drug adulterant testing supplies to any person.
22 § 3. This act shall take effect immediately.